Dabigatran-induced bleeding: antidote (idarucizumab) on the way
www.pulmccm.org
New oral anticoagulants like dabigatran, apixaban and rivaroxaban have advantages over warfarin: not requiring regular monitoring for efficacy; faster onset of action; shorter half-lives. Unlike warfarin, they've had the significant disadvantage of having no proven antidote for the bleeding that inevitably occurs when any anticoagulant is given to thousands of people. [lawsuits]
Dabigatran-induced bleeding: antidote (idarucizumab) on the way
Dabigatran-induced bleeding: antidote…
Dabigatran-induced bleeding: antidote (idarucizumab) on the way
New oral anticoagulants like dabigatran, apixaban and rivaroxaban have advantages over warfarin: not requiring regular monitoring for efficacy; faster onset of action; shorter half-lives. Unlike warfarin, they've had the significant disadvantage of having no proven antidote for the bleeding that inevitably occurs when any anticoagulant is given to thousands of people. [lawsuits]